(Q42551725)

2 November 2017

title

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke (English)

1 reference

2 November 2017

author

Hans-Christoph Diener

1

object named as

Diener HC

1 reference

2 November 2017

Cunha L

2

1 reference

2 November 2017

Forbes C

3

1 reference

2 November 2017

Sivenius J

4

1 reference

2 November 2017

Smets P

5

1 reference

2 November 2017

Lowenthal A

6

1 reference

2 November 2017

publication date

1 November 1996

1 reference

Journal of the Neurological Sciences

2 November 2017

published in

1 reference

2 November 2017

volume

143

1 reference

2 November 2017

issue

1-2

1 reference

2 November 2017

page(s)

1-13

1 reference

Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP.

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900308-5

Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900308-5

7 January 2021

Epidemiology of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900308-5

"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900308-5

European Stroke Prevention Study. ESPS Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900308-5

Controlled trial of aspirin in cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900308-5

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900308-5

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900308-5

Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900308-5

Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900308-5

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900308-5

Interobserver agreement for the assessment of handicap in stroke patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900308-5

10.1016/S0022-510X(96)00308-5

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference